These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17919376)

  • 1. [The expression of MRP, GST-pi, Topo IIalpha and COX-2 in epithelial ovarian cancer and its relationship to drug resistance and prognosis].
    Cao DY; Shen K; Yang JX; Guan J
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1738-41. PubMed ID: 17919376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma].
    Yu DQ; Yi YF
    Ai Zheng; 2003 May; 22(5):496-9. PubMed ID: 12753710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance-associated biomarkers PGP, GST-pi, Topo-II and LRP as prognostic factors in primary ovarian carcinoma.
    Lu D; Shi HC; Wang ZX; Gu XW; Zeng YJ
    Br J Biomed Sci; 2011; 68(2):69-74. PubMed ID: 21706917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines.
    Wang J; Zhang J; Zhang L; Zhao L; Fan S; Yang Z; Gao F; Kong Y; Xiao GG; Wang Q
    Oncol Rep; 2011 Nov; 26(5):1081-9. PubMed ID: 21805041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and implication of Pgp, MRP, LRP, GST-pi, Topo II alpha in tongue squamous cell carcinoma].
    Leng WD; Wang DZ; Feng G; He J
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Feb; 22(1):23-5. PubMed ID: 15017692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer.
    Naniwa J; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Shimada M; Shimogai R; Kawaguchi W; Sato S; Terakawa N
    Int J Gynecol Cancer; 2007; 17(1):76-82. PubMed ID: 17291235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of multidrug resistance gene-associated proteins in the postoperative adjuvant chemotherapy for gastric carcinoma and the prognosis].
    Yu PF; Guo JM; Xu Q; Ying JE; Wang XJ; Cheng XD; Wang XB; Yu CD
    Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Apr; 13(4):289-93. PubMed ID: 20422488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas.
    Koshiyama M; Fujii H; Kinezaki M; Morita Y; Nanno H; Yoshida M
    Anticancer Res; 2001; 21(4B):2925-32. PubMed ID: 11712788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of P-gp, GST-pi and Topo II alpha in gastric and colorectal cancers and their clinical significance].
    Chen WY; Mao WM; Zhao L; Chen GP; Shu Y; Shen YF; Zhu XH; Xia Y
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):738-40. PubMed ID: 16483485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic importance of survivin, Ki-67, and topoisomerase IIα in ovarian carcinoma.
    Kucukgoz Gulec U; Gumurdulu D; Guzel AB; Paydas S; Seydaoglu G; Acikalin A; Khatib G; Zeren H; Vardar MA; Altintas A
    Arch Gynecol Obstet; 2014 Feb; 289(2):393-8. PubMed ID: 23974278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between combined multigene detection and response to chemotherapy and prognosis in epithelial ovarian carcinomas].
    Li L; Mo XY; Zhang W; Wei MY; Chen FL; Yao DS
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):600-4. PubMed ID: 17983514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of multidrug resistance gene-related proteins in the postoperative chemotherapy of gastric cancer.
    Yu P; Du Y; Yang L; Fan S; Wu J; Zheng S
    Int J Clin Exp Pathol; 2014; 7(11):7945-50. PubMed ID: 25550836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer.
    Kreisholt J; Sorensen M; Jensen PB; Nielsen BS; Andersen CB; Sehested M
    Br J Cancer; 1998 May; 77(9):1469-73. PubMed ID: 9652763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The expression of multiple drug resistance associated genes in ovarian cancer].
    Cheng G; Zhu H; Sun L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):87-90. PubMed ID: 11809106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells.
    Matsumoto Y; Takano H; Kunishio K; Nagao S; Fojo T
    Jpn J Cancer Res; 2001 Jul; 92(7):778-84. PubMed ID: 11473729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.
    Dingemans AM; Witlox MA; Stallaert RA; van der Valk P; Postmus PE; Giaccone G
    Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship of cyclooxygenase-2 and multidrug resistance associated factors to chemosensitivities in gastrointestinal carcinomas].
    Tan BB; Li Y; Han J; Fan LQ; Zhao Q; Song ZC; Wang D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):128-31. PubMed ID: 20369487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between the p53/topoisomerase I and p53/ topoisomerase IIalpha immunophenotypes and the progression of ovarian carcinomas.
    Bar JK; Grelewski P; Noga L; Rabczyński J; Gryboś M; Jeleń M
    Adv Clin Exp Med; 2012; 21(1):35-42. PubMed ID: 23214297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.